| Literature DB >> 7737424 |
J Okabe-Kado1, T Kasukabe, M Hozumi, Y Honma, N Kimura, H Baba, T Urano, H Shiku.
Abstract
We recently identified a differentiation inhibiting factor (I-factor) in mouse myeloid leukemia M1 cells as a murine homolog of nm23-H2/nucleoside diphosphate kinase (NDPK)-B gene product. We examined the I-factor activities of several authentic nm23/NDPK proteins, i.e. recombinant rat NDPK alpha and beta, recombinant mouse nm23-M1 and -M2, and recombinant human nm23-H1 and -H2 containing a mutant nm23-H2His protein lacing NDPK activity. Almost all these nm23/NDPK proteins showed I-factor activity. Moreover, to understand the active domain exhibiting I-factor activity of nm23-H2 protein lacking NDPK activity, we have investigated the I-factor activities of some truncated nm23-H2 proteins. The truncated nm23-H2 protein containing N-terminal peptide 1-60 retained the I-factor activity. These results provide the first evidence for a function of nm23/NDPK as a differentiation inhibiting factor in leukemic cells, that is independent of its NDPK activity and dependent on the presence of N-terminal peptide.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7737424 DOI: 10.1016/0014-5793(95)00338-a
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124